These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 23385246)

  • 1. Genetic studies provide new insights into breast cancer biology and treatment.
    Hampton T
    JAMA; 2013 Feb; 309(5):427-9. PubMed ID: 23385246
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
    Pinto AE; André S; Pereira T; Silva G; Soares J
    Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone receptors in breast carcinomas.
    Mandal AK
    Indian J Pathol Microbiol; 1995 Jan; 38(1):109-18. PubMed ID: 8919478
    [No Abstract]   [Full Text] [Related]  

  • 4. Less frequent promoter hypermethylation of DLC-1 gene in primary breast cancers.
    Teramoto A; Tsukuda K; Yano M; Toyooka S; Dote H; Doihara H; Shimizu N
    Oncol Rep; 2004 Jul; 12(1):141-4. PubMed ID: 15201975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation and breast carcinogenesis.
    Widschwendter M; Jones PA
    Oncogene; 2002 Aug; 21(35):5462-82. PubMed ID: 12154408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.
    Fujita N; Nakayama T; Yamamoto N; Kim SJ; Shimazu K; Shimomura A; Maruyama N; Morimoto K; Tamaki Y; Noguchi S
    Oncology; 2012; 83(5):273-82. PubMed ID: 22964822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
    Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
    Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of breast cancer DNA methylation markers optimized for fine-needle aspiration samples.
    Bu D; Lewis CM; Sarode V; Chen M; Ma X; Lazorwitz AM; Rao R; Leitch M; Moldrem A; Andrews V; Gazdar A; Euhus D
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2212-21. PubMed ID: 24089458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of ER gene CpG island methylation-specific polymerase chain reaction.
    Lapidus RG; Nass SJ; Butash KA; Parl FF; Weitzman SA; Graff JG; Herman JG; Davidson NE
    Cancer Res; 1998 Jun; 58(12):2515-9. PubMed ID: 9635570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
    Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
    Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
    Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene expression analysis and its clinical use in breast tumors].
    Semiglazov VF; Semiglazov VV; Moiseenko FV; Bogdanov AA; Boĭtsov VV; Viaz'min SV; Gorab DN; Chubenko VA; Brezhnev NV; Luk'ianchikova VS; Dubina MV
    Vopr Onkol; 2013; 59(1):25-9. PubMed ID: 23805447
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of DNA methylation markers for human breast carcinomas using the methylation-sensitive restriction fingerprinting technique.
    Huang TH; Laux DE; Hamlin BC; Tran P; Tran H; Lubahn DB
    Cancer Res; 1997 Mar; 57(6):1030-4. PubMed ID: 9067264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.
    Hoque MO; Feng Q; Toure P; Dem A; Critchlow CW; Hawes SE; Wood T; Jeronimo C; Rosenbaum E; Stern J; Yu M; Trink B; Kiviat NB; Sidransky D
    J Clin Oncol; 2006 Sep; 24(26):4262-9. PubMed ID: 16908936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Largest ever DNA methylation dataset for breast cancer completed.
    Dedeurwaerder S; Desmedt C; Calonne E
    Expert Rev Mol Diagn; 2011 Jun; 11(5):470. PubMed ID: 21842555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes].
    Stöger H
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2096. PubMed ID: 24085364
    [No Abstract]   [Full Text] [Related]  

  • 18. Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?
    Cristofanilli M; Mendelsohn J
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17073-4. PubMed ID: 17090687
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequencing efforts help to refine the molecular classification of breast cancer.
    Konecny GE
    Curr Opin Obstet Gynecol; 2014 Feb; 26(1):18-20. PubMed ID: 24346129
    [No Abstract]   [Full Text] [Related]  

  • 20. [Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? No].
    Gampenrieder SP
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2097. PubMed ID: 24085365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.